After participating in this educational activity, attendees should be able to:
1. Understand health abnormalities that have been associated with in utero HIV exposure in HIV-negative individuals.
2. Become familiar with the concept of the developmental origins of health and disease, and how this might be applied to the HEU population.
3. Recognize the limitations of current knowledge of HEU outcomes, and how further studies are needed.
Daniel J. Skiest, MD
The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Faculty or planner conflicts of interest are resolved before the educational activity.
Dr. Skiest (Planner)receives grant/research support from Glaxo SmithKline-VIIV.
None of the other members of the planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 BCIPE Instructional Hours